1. Home
  2. TNGX vs WNC Comparison

TNGX vs WNC Comparison

Compare TNGX & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • WNC
  • Stock Information
  • Founded
  • TNGX 2014
  • WNC 1985
  • Country
  • TNGX United States
  • WNC United States
  • Employees
  • TNGX 140
  • WNC N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • WNC Construction/Ag Equipment/Trucks
  • Sector
  • TNGX Health Care
  • WNC Industrials
  • Exchange
  • TNGX Nasdaq
  • WNC Nasdaq
  • Market Cap
  • TNGX 747.9M
  • WNC 859.9M
  • IPO Year
  • TNGX N/A
  • WNC 1991
  • Fundamental
  • Price
  • TNGX $6.98
  • WNC $18.14
  • Analyst Decision
  • TNGX Strong Buy
  • WNC Hold
  • Analyst Count
  • TNGX 8
  • WNC 2
  • Target Price
  • TNGX $15.14
  • WNC $20.50
  • AVG Volume (30 Days)
  • TNGX 1.3M
  • WNC 621.1K
  • Earning Date
  • TNGX 11-06-2024
  • WNC 10-23-2024
  • Dividend Yield
  • TNGX N/A
  • WNC 1.76%
  • EPS Growth
  • TNGX N/A
  • WNC N/A
  • EPS
  • TNGX N/A
  • WNC 3.27
  • Revenue
  • TNGX $42,509,000.00
  • WNC $2,294,814,000.00
  • Revenue This Year
  • TNGX $18.15
  • WNC N/A
  • Revenue Next Year
  • TNGX N/A
  • WNC $4.64
  • P/E Ratio
  • TNGX N/A
  • WNC $5.52
  • Revenue Growth
  • TNGX 26.16
  • WNC N/A
  • 52 Week Low
  • TNGX $5.15
  • WNC $17.71
  • 52 Week High
  • TNGX $13.01
  • WNC $30.07
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 33.20
  • WNC 37.07
  • Support Level
  • TNGX $6.72
  • WNC $18.46
  • Resistance Level
  • TNGX $7.78
  • WNC $19.57
  • Average True Range (ATR)
  • TNGX 0.56
  • WNC 0.54
  • MACD
  • TNGX -0.11
  • WNC -0.09
  • Stochastic Oscillator
  • TNGX 8.48
  • WNC 6.79

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: